Newsroom
Labs@Home™ Facilitates Outpatient Management of Kidney Transplants During COVID-19 – TruGraf® and Labs@Home reduce risks of surveillance biopsies during COVID-19
Mansfield, MA, May 21, 2020 — MANSFIELD, MA., Transplant Genomics, Inc. (“TGI”), Following the launch in April 2020 of Labs@Home in response to…
Dr. Peter Meintjes Joins Transplant Genomics as Chief Commercial Officer
Mansfield, MA, April 28, 2020 — MANSFIELD, MA., Eurofins -Transplant Genomics, Inc. (“TGI”), announces that Dr. Peter Meintjes has joined the…
Eurofins – Transplant Genomics Announces TRULO Registry Study to Evaluate Long-Term Clinical Outcomes in Patients Monitored with TruGraf® Testing
Mansfield, MA, April 15, 2020 — MANSFIELD, Mass., Eurofins – Transplant Genomics (“TGI”), a molecular diagnostics company committed to improving organ…
Remote Testing Options to Support Care for Kidney Transplant Recipients
March 18, 2020 — Eurofins is committed to supporting physicians in providing optimal care for their transplant patients. With the outbreak…
Transplant Genomics, Inc. Appoints Dr. John Holman as VP Medical Affairs
Mansfield, MA, January 10, 2020 — MANSFIELD, Mass., Transplant Genomics, Inc. (“TGI”), a molecular diagnostics company committed to improving organ transplant…
Transplant Genomics, Inc. Founders Awarded US Patent Covering Detection of “Silent” Sub-Clinical Rejection in Stable Kidney Transplant Recipients
Mansfield, MA, October 29, 2019 — MANSFIELD, Mass., Transplant Genomics, Inc. (“TGI”), a molecular diagnostics company committed to improving organ transplant…
Transplant Genomics, Inc. Confirms TruGraf® Will Receive Medicare Coverage Effective November 25, 2019
Mansfield, MA, October 11, 2019 — Transplant Genomics, Inc. (“TGI”), a molecular diagnostics company committed to improving organ transplant outcomes with non-invasive…
Medicare Issues Draft Local Coverage Determination (LCD) for Transplant Genomics’ TruGraf® Blood Test as Alternative to Surveillance Biopsies
Mansfield, MA, March 29, 2019 — Transplant Genomics Inc. (TGI) announces that Palmetto GBA has released a draft local coverage determination (LCD) for…
Studies Presented at American Transplant Congress Support Clinical Utility of TGI’s TruGraf® Tests for Management of Kidney Transplant Recipients
Mansfield, MA, June 12, 2018 — Transplant Genomics Inc. (TGI), a molecular diagnostics company committed to improving organ transplant outcomes, presented…
Clinical Utility Study Indicates Potential for TruGraf™ Test to Replace Surveillance Biopsies in Kidney Transplant Recipients with Stable Renal Function
Mansfield, MA, November 28, 2017 — Transplant Genomics Inc. (TGI), a molecular diagnostics company committed to improving organ transplant outcomes, has published…